503PActivity of afatinib in patients (pts) with NSCLC...

Annals of Oncology 2019 / 11 Vol. 30; Iss. Supplement

503PActivity of afatinib in patients (pts) with NSCLC harboring uncommon EGFR mutations: Pooled analysis of three large phase IIIB trials

Passaro, A, De Marinis, F, Tu, H, Laktionov, K K, Feng, J, Poltoratskiy, A, Zhao, J, Tan, E-H, Gottfried, M, Lee, V, Kowalski, D, Yang, C-T, Srinivasa, B, Clementi, L, Tang, W, Huang, D C-L, Cseh, A,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz437.029
Date:
November, 2019
File:
PDF, 104 KB
english, 2019
Conversion to is in progress
Conversion to is failed